Skip to main content
Clinical Trials/TCTR20180112001
TCTR20180112001
Completed
Phase 3

Effects of High Frequency Repetitive Transcranial Magnetic Stimulation and Sertraline on Depressive Symptoms in Patients after Ischemic Stroke

Faculty of Medicine Chulalongkorn University0 sites15 target enrollmentJanuary 12, 2018

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Post stroke depression
Sponsor
Faculty of Medicine Chulalongkorn University
Enrollment
15
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2018
End Date
January 12, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Ischemic stroke patients
  • \-Age 18 years or more
  • \-Have depressive symptoms (diagnosed with DSM\-IV\-TR)
  • \-No antidepressant taken

Exclusion Criteria

  • \-Have other neurological diseases
  • \-Had depression prior to stroke
  • \-Had seizure, epilepsy or history of head trauma
  • \-Have pacemaker or metallic implant inside the brain
  • \-Inability to communicate
  • \-Thai Mental State Examination (TMSE) score less than 23

Outcomes

Primary Outcomes

Not specified

Similar Trials